Evolent Health Explores Sale, Garners Inbound Interest From Private Equity Firms
A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $38 to $45
Evolent Health Better Suited for Leveraged Buyout Than Strategic Deal With Health Insurer, Truist Says
Evolent Health Could See $35 a Share or More in a Takeover - Analyst
Evolent Health: A Strong Buy Amid Acquisition Interest and Proactive Revenue Strategies
Form 144 | Evolent Health(EVH.US) Officer Proposes to Sell 5.63 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 22, $Evolent Health(EVH.US)$ Officer Blackley Seth intends to sell 187.9K shares of its common stock on Aug 22, with a total market value of approximately $5.63 million.
Sector Update: Health Care Stocks Softer in Afternoon Trading
Market Chatter: Evolent Health in Discussions Over Potential Sale
Street Color: Evolent Health in Discussions Over Potential Sale, Reuters Says
Evolent Health Shares Are Trading Higher Following a Report Suggesting That the Company Is Exploring a Sale.
Express News | Evolent Health Explores Sale Following Acquisition Interest; Potential Bidders Include TPG, CD&R, KKR, And Elevance Health
Express News | Exclusive-Evolent Health Is Exploring a Sale After Receiving Acquisition Interest, Sources Say
Oppenheimer's Top 32 Ideas for August-September
Evolent Health Is Maintained at Overweight by JP Morgan
Evolent Health Analyst Ratings
J.P. Morgan Maintains Evolent Health(EVH.US) With Buy Rating, Announces Target Price $45
Engaged Capital Adds Smartsheet, Reduces Stakes in Shake Shack, Others in Q2
CCORF Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $33
Evolent Health Poised for Growth: Strategic Acquisition and Strong Organic Prospects Fuel Buy Rating
Express News | Evolent Health Inc : Stephens Cuts Target Price to $32 From $42